GeoVax Labs Raises $3M AT Market Financing with $1.48 Warrants
GeoVax Labs agreed to sell 2,027,027 shares and accompanying Series A and B warrants at a $1.48 exercise price, raising approximately $3 million in an at-the-market private placement. The company expects to close the offering around May 19, 2026, using proceeds for working capital and general corporate purposes.
1. Financing Structure
GeoVax Labs entered into a securities purchase agreement with existing institutional investors to sell 2,027,027 shares of common stock through an at-the-market offering, generating gross proceeds of about $3 million before fees.
2. Closing and Use of Proceeds
The closing is expected on or about May 19, 2026, subject to customary conditions. Net proceeds will be allocated to working capital and general corporate purposes to support ongoing development efforts.
3. Warrant Terms and Expiration
The deal includes Series A warrants exercisable at $1.48 per share for five years and Series B warrants at the same strike price for 18 months, offering potential additional capital upon exercise.
4. Placement Agent and Regulatory Filing
A.G.P./Alliance Global Partners is acting as sole placement agent. GeoVax has agreed to file a registration statement covering the resale of the shares and underlying warrants in compliance with securities laws.